RBC Capital Maintains Sector Perform on WAVE Life Sciences, Raises Price Target to $15

Benzinga · 10/21 13:51
RBC Capital analyst Luca Issi maintains WAVE Life Sciences (NASDAQ:WVE) with a Sector Perform and raises the price target from $7 to $15.